PLPC Q1 2026 Earnings EPS Surges Past Estimates with 1528 Surprise Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises KDP Q1 2026 Earnings Earnings Beat Drives Modest Stock Uptick Amid Revenue Disclosures Uncertainty Mineralys Therapeutics MLYS Q1 2026 Earnings Narrowerthanexpected Loss as Clinical Progress Continues CFFI Q1 2026 Earnings Solid EPS Performance Amid Modest Stock Decline SYM Q1 2026 Earnings EPS Misses Estimates by 804 Stock Rallies Despite Setback